IN2013MU02031A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02031A
IN2013MU02031A IN2031MU2013A IN2013MU02031A IN 2013MU02031 A IN2013MU02031 A IN 2013MU02031A IN 2031MU2013 A IN2031MU2013 A IN 2031MU2013A IN 2013MU02031 A IN2013MU02031 A IN 2013MU02031A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Dhrumill G Shah
Ashok Potdar
Original Assignee
Novoexcipients Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novoexcipients Pvt Ltd filed Critical Novoexcipients Pvt Ltd
Priority to IN2031MU2013 priority Critical patent/IN2013MU02031A/en
Publication of IN2013MU02031A publication Critical patent/IN2013MU02031A/en

Links

IN2031MU2013 2013-06-14 2013-06-14 IN2013MU02031A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2031MU2013 IN2013MU02031A (enrdf_load_stackoverflow) 2013-06-14 2013-06-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2031MU2013 IN2013MU02031A (enrdf_load_stackoverflow) 2013-06-14 2013-06-14

Publications (1)

Publication Number Publication Date
IN2013MU02031A true IN2013MU02031A (enrdf_load_stackoverflow) 2015-06-05

Family

ID=54396333

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2031MU2013 IN2013MU02031A (enrdf_load_stackoverflow) 2013-06-14 2013-06-14

Country Status (1)

Country Link
IN (1) IN2013MU02031A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111670035A (zh) * 2018-02-02 2020-09-15 尤斯特拉里斯制药有限公司（以普雷舒拉纽罗作为商号） 经口制剂及其用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111670035A (zh) * 2018-02-02 2020-09-15 尤斯特拉里斯制药有限公司（以普雷舒拉纽罗作为商号） 经口制剂及其用途
EP3746078A4 (en) * 2018-02-02 2021-11-17 Eustralis Pharmaceuticals Limited (Trading as Pressura Neuro) ORAL FORMULATIONS AND USES THEREOF

Similar Documents

Publication Publication Date Title
BR112015007533A2 (enrdf_load_stackoverflow)
BR112014018502A2 (enrdf_load_stackoverflow)
BR112014019326A2 (enrdf_load_stackoverflow)
BR112014018516A2 (enrdf_load_stackoverflow)
BR112016003862A2 (enrdf_load_stackoverflow)
BR112014018480A2 (enrdf_load_stackoverflow)
BR112014020341A2 (enrdf_load_stackoverflow)
BR112016000215A2 (enrdf_load_stackoverflow)
BR112014021878A2 (enrdf_load_stackoverflow)
BR112014018468A2 (enrdf_load_stackoverflow)
BR112014019204A2 (enrdf_load_stackoverflow)
BR112014018207A2 (enrdf_load_stackoverflow)
BR112015015948A2 (enrdf_load_stackoverflow)
BR112016004932A2 (enrdf_load_stackoverflow)
BR112014018578A2 (enrdf_load_stackoverflow)
BR112014018483A2 (enrdf_load_stackoverflow)
BR112016015216A2 (enrdf_load_stackoverflow)
BR112016014908A2 (enrdf_load_stackoverflow)
BR112014017601A2 (enrdf_load_stackoverflow)
BR112015015312A2 (enrdf_load_stackoverflow)
BR112014024039A2 (enrdf_load_stackoverflow)
BR112014018353A2 (enrdf_load_stackoverflow)
BR112014018496A2 (enrdf_load_stackoverflow)
BR112016005512A2 (enrdf_load_stackoverflow)
BR112014018514A2 (enrdf_load_stackoverflow)